Oral Session (Oral presentations categorized by each organ) O3 À 3 À 4 PHASE II STUDY OF PEMETREXED + ERLOTINIB IN PRETREATED Non-Sq-NSCLC Pts WITH wtEGFR (TALIMTA STUDY)
ID:am030003M003519ofyk699📫 -页
内容摘要
Oral Session (Oral presentations categorized by each organ) O3 À 3 À 4 PHASE II STUDY OF PEMETREXED + ERLOTINIB IN PRETREATED Non-Sq-NSCLC Pts WITH wtEGFR (TALIMTA STUDY)
海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方,仅供网友学习交流,请勿商用!

